Kyphoplasty/vertebroplasty: Indications and Outcomes | How do GLP1s Affect Sarcopenia and MBD/OP?

Includes a Live Web Event on 04/12/2026 at 10:00 AM (EDT)

Kyphoplasty/vertebroplasty: Indications and Outcomes

Daniel Holzwanger, MD

Sunday, April 12, 2026, 10:00am to 10:30am Eastern Time (NY/USA)

  

How do GLP1s Affect Sarcopenia and MBD/OP

Shirine E. Usmani, MD, PhD, FRCPC

Sunday, April 12, 2026, 10:30am to 11:00am Eastern Time (NY/USA)

Description

GLP-1 receptor agonists are now widely used for the management of diabetes and overweight/obesity.  Concerns have been raised about their potential impact on skeletal muscle and bone density. This talk will look at the evidence to date regarding how this class of medication impacts bone and muscle health and will highlight future areas of investigation.

Daniel J. Holzwanger, MD

Interventional Radiologist

Weill Cornell Medicine

Daniel J. Holzwanger, MD is an Interventional Radiologist and Assistant Professor of Clinical Radiology at Weill Cornell Medicine and New York-Presbyterian Hospital. He earned his medical degree from Weill Cornell Medical College and completed his Diagnostic Radiology residency at New York-Presbyterian/Weill Cornell Medical Center, where he served as Chief Resident. He subsequently completed fellowship training in Vascular and Interventional Radiology at Vanderbilt University Medical Center. His clinical practice focuses on image-guided musculoskeletal and spine interventions, including vertebral augmentation, tumor ablation, nerve ablation, and embolization therapies for pain and oncology care, with ongoing research aimed at advancing minimally invasive treatments for musculoskeletal and cancer-related pain.

Shirine E. Usmani, MD, PhD, FRCPC

Assistant Professor, Clinician Investigator and Staff Physician

University of Toronto, University Health Network, Toronto ON

Dr. Shirine Usmani completed her undergraduate degree in Physiology and Pharmacology at Western University before entering the MD/PhD program, also at Western. Her PhD focused on musculoskeletal health, specifically understanding molecular mechanisms involved in bone development and osteoarthritis. Dr. Usmani then went on to complete her residency training in Internal Medicine with a sub-specialization in Endocrinology at the University of Toronto. She completed a Post-Doctoral Fellowship through Toronto's Clinician Scientist Training Program with a focus on sarcopenia and genetic regulators of muscle mass. In October 2024 she started a full-time position as a Clinician Investigator/Assistant Professor at the University Health Network (UHN)/University of Toronto. Her research focuses on clinical and translational research through the UHN Osteoporosis and Metabolic Bone clinic.

This content will not be available until 04/12/2026 at 8:00 AM (EDT)